Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03551392 · ClinicalTrials.gov registry record · NA
Pilot Intervention With Near Infrared Stimulation
A NA study of Aging, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 2
- Study locations
NCT03551392: Recruiting NA study of Aging, sponsored by University of Florida.
NCT03551392 is a NA study of Aging that is actively recruiting participants, run by University of Florida. The registered enrollment target is 24 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03551392, a NA study of Aging, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 2
- Study locations
Study Summary
The current study will test whether age-related cognitive and mood changes in older adults and those will be affected by near infrared (NIR) stimulation. The overall hypothesis, drawn from previous literature, is that exposure to NIR stimulation will have positive effects on brain health and will result in better cognitive and mood performance.
Primary Outcome
Spatial navigation and memory task yields a score consisting of percent time spent in the target quadrant during the probe trial.
Conditions Studied
Interventions
- DEVICE Medx Console System
- DEVICE Sham Medx Console System
- DEVICE Vielight 810 intranasal stand alone unit
- DEVICE Sham Vielight 810 intranasal stand alone unit
Study Locations (2)
Arizona
- University of Arizona - Tucson
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2019-06-26 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What NCT03551392 shows while recruiting
NCT03551392 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 4 interventions - of which Medx Console System is the first listed.
NCT03551392 reports a single indexed study location in Arizona, Florida.
Frequently Asked Questions
What is clinical trial NCT03551392 about?
NCT03551392 is a clinical study titled "Pilot Intervention With Near Infrared Stimulation". The current study will test whether age-related cognitive and mood changes in older adults and those will be affected by near infrared (NIR) stimulation. The overall hypothesis, drawn from previous literature, is that exposure to NIR stimulation will have positive effects on brain health and will re...
What is the current status of trial NCT03551392?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2019-06-26. Estimated completion is 2026-04-30.
What conditions does trial NCT03551392 study?
This clinical trial studies the following conditions: Aging.
What interventions are being tested in trial NCT03551392?
The interventions under investigation include: Medx Console System (DEVICE), Sham Medx Console System (DEVICE), Vielight 810 intranasal stand alone unit (DEVICE), Sham Vielight 810 intranasal stand alone unit (DEVICE).
Who is sponsoring clinical trial NCT03551392?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03551392 being conducted?
This trial has 2 study locations across Arizona, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03551392's enrollment target sits among peer trials
24 214th of 262 higher than 40 of 262 other Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Using Nicotine to Reverse Age-related Auditory Processing Deficits
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
-
Studying the Effects of Digital Interventions on Cognition, Wellbeing, Stress, and Sleep in Older Adults
RECRUITING · NA
-
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI